Roche Holdings, Inc.
Roche Holdings, Inc., commonly referred to as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established a strong presence in the pharmaceutical and diagnostics industries, with significant operations across Europe, Asia, and the Americas. The company is renowned for its innovative approach to personalised medicine, focusing on oncology, immunology, and infectious diseases. Roche's core products include cutting-edge pharmaceuticals and advanced diagnostic tools, which are distinguished by their commitment to research and development. With a robust market position, Roche has achieved numerous milestones, including being a pioneer in biotechnology and maintaining a strong portfolio of blockbuster drugs. The company's dedication to improving patient outcomes solidifies its reputation as a leader in the healthcare sector.
DitchCarbon Score
How does Roche Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Holdings, Inc.'s score of 83 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Holdings, Inc., headquartered in the US, currently does not provide specific carbon emissions data for the latest reporting year. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and emissions reporting. As part of its climate strategy, Roche Holdings, Inc. inherits emissions data and reduction initiatives from Roche Holding AG. However, there are no documented reduction targets or specific climate pledges available for Roche Holdings, Inc. at this time. The absence of detailed emissions data and reduction targets suggests that the company may still be in the process of establishing its own climate commitments or aligning with those of its parent organisation. Roche Holding AG has been active in addressing climate change, and any future emissions data or commitments from Roche Holdings, Inc. may reflect the broader goals set by its parent company. As the landscape of corporate climate action evolves, Roche Holdings, Inc. may adopt more defined targets and initiatives in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 320,860,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 209,660,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
